New Roche test aids clinicians in accelerating tuberculosis diagnosis and treatment by detecting antimicrobial resistance within the world ’s leading cause of infectious disease deaths
Roche today announced the CE-IVD launch of the cobas ® MTB-RIF/INH test to detect resistance to antibiotics within tuberculosis DNA.
Source: Roche Media News - Category: Pharmaceuticals Source Type: news
More News: Antimicrobial Resistance | HIV AIDS | Infectious Diseases | Pharmaceuticals | Tuberculosis